Form 4: Zymeworks Inc. Executive Granted Stock Options

Zymeworks Inc. has granted stock options to an executive, exercisable at $13.06 per share, vesting after the next annual general meeting.

Summary

• Zymeworks Inc. granted stock options to Susan C. Mahony on December 10, 2024.
• The options allow the purchase of 31,000 shares of common stock at an exercise price of $13.06 per share.
• The options vest on the date of the next annual general meeting following the grant date.
• The options expire on December 9, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock options to executives, which is generally viewed positively as an incentive mechanism. There are no indications of negative sentiment.

Positives

• The granting of stock options can serve as an incentive for the executive to perform well.
• The vesting period aligns the executive's interests with the long-term performance of the company.

Risks

• The value of the stock options is dependent on the future performance of Zymeworks Inc.'s stock price.
• If the stock price does not increase above the exercise price, the options may not be valuable to the executive.

Future Outlook

The stock options will vest after the next annual general meeting following the grant date.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard practice for incentivizing executives in publicly traded companies, particularly in the biotech sector.
• The vesting period tied to the annual general meeting is a common mechanism to ensure long-term alignment.
• The exercise price of $13.06 would be compared to the current market price of Zymeworks stock to determine the immediate value of the options.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for management.
• The executive receiving the options is incentivized to increase the company's value.

Next Steps

• The stock options will vest after the next annual general meeting following the grant date.

Key Dates

Keywords

stock options, executive compensation, equity, vesting, Zymeworks Inc., ZYME